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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Myocardial infarction is a major public health concern and the
leading cause of death throughout the world. The present study
investigates the ability of Aegle marmelos fruit extract to prevent
pathological changes and oxidative stress after isoproterenol
induced myocardial infarction in rats. In vitro studies showed that
Aegle marmelos fruit extract possesses antioxidant activity.
Administration of isoproterenol (85 mg/kg body weight) to rats
resulted in significantly elevated plasma transaminases, lactate
dehydrogenase and creatine kinase, however, cardiac tissue anal-
yses showed decreased activity of the above enzymes compared
to experimental control rats. Further, isoproterenol administration
significantly increased plasma and cardiac tissue thiobarbituric acid
reactive substances and lowered the activities of cardiac tissue
superoxide dismutase, catalase, reduced glutathione, glutathione
peroxidase and glutathione-S-transferase when compared to
control groups. Pretreatment with Aegle marmelos fruit extract
at a dose of 150 mg/kg body weight for a period of 45 days sig-
nificantly prevented the observed alterations. Our data suggest
that Aegle marmelos fruit extract exerts its protective effect by
decreasing thiobarbituric acid reactive substances and elevating
antioxidants status in isoproterenol treated rats. Both biochemical
and histopathological results in the isoproterenol-induced myocar-
dial infarction model emphasize the beneficial action of Aegle
marmelos fruit extract as a cardioprotective agent.
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Introduction Myocardial infarction (MI) is the major form of ischemic
heart diseases (IHD) and is characterized by an imbalance
of coronary blood supply and myocardial demand which results in
ischemia and myocardial death.(1) Previous studies have shown
that during ischemic injury, oxidative stress produced by the
generation of reactive oxygen species (ROS) plays a key role in
the development of MI.(2,3) To scavenge ROS, cells have several
antioxidant enzymes, the protective action of these enzymes is
usually due to the inhibition of free radical-induced chain reaction
and the resultant prevention of peroxidative deterioration of
structural lipids in membranous organelles.(4,5)
Isoproterenol (ISO), a synthetic β-adrenoceptor agonist induces
cardiotoxicity in the form of MI in rats as a result of disturbance in
physiological balance between production of free radicals and
antioxidative defense system.(6) Various mechanisms have been
proposed to explain the ISO-induced cardiac damage, generation
of highly cytotoxic free radicals through the auto-oxidation of
catecholamine has been implicated as one of the important
causative factors.(7) A better understanding of the processes
involved in the pathophysiology of MI has led the researchers to
search for safer medication that can limit the extent of myocardial
injury.(8) Previous studies have demonstrated that use of anti-
oxidants as a preventive approach to attenuate myocardial dys-
function and limit the infarct size as well as slow down the
progression and consequences of MI. Recently, there has been
renewed interest in medicinal plants that have been found to have
certain preventive measures in the treatment of cardiovascular
diseases.(9) Many plant products are rich in polyphenolics
including tannins and flavonoids, which are group of compounds
with diverse in chemical structure, characteristics and widely
recognized as naturally occurring antioxidants.(10) Reports
revealed that compounds in their natural formulations are more
active than isolated form, since they contain both dotes and
antidotes.(11)
There is a growing interest in traditionally used medicinal
plants which produce a variety of compounds having therapeutic
properties.(12) One such medicinal plant used since ancient time is
Aegle marmelos (L.), commonly known as Bael and belongs to the
family Rutaceae. Medicinal properties of Aegle marmelos were
well explained in Ayurveda, Indian traditional medicine.(13) Aegle
marmelos fruit are reported to be contain several active principles
like marmelosin, marmelide, Luvangetin, aurapten, psoralen,
tannin.(14,15) The fruit extract of Aegle marmelos have demonstrated
antidiabetic,(16) antihyperlipidemic,(17) gastroprotective and anti-
diarrhoeal,(18,19) radioprotective,(20) antimicrobial,(21) activities.
Previous studies showed preventive role of Aegle marmelos leaf
extract on isoprenaline-induced MI.(17) Though Aegle marmelos
fruit has several therapeutic properties, it has not been tested
against experimentally induced MI. Hence, the present study was
planned to evaluate the preventive effect of AMFE on iso-
proterenol induced oxidative stress in MI of rats.
Materials and Methods
Chemicals. ISO (D,L-4-(2-(isopropylamino)-1-hydroxyethyl)
pyrocatechol) used to induce cardiac damage was purchased
from Sigma-Aldrich (St. Louis, MO). All other chemicals were
of analytical grade and were supplied by Sisco Research Labo-
ratories (Mumbai, India).
Preparation of Aegle marmelos unripe fruit extract.
Fresh  Aegle marmelos unripe fruits were collected around Sri
Krishnadevaraya University premises and verified with specimens
available at the Botanical Herbarium, Dept of Botany, Sri
Krishnadevaraya University, Anantapur, India. Fruits were air
dried and powdered in an electric blender. The powder was boiled
in distilled water. After filtration through whatmann No.40 filter
paper the extract was evaporated to dryness by slow heating and
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continuous stirring in a water bath. The dark brown residue left
behind was collected and was used for the study. The extract
contains 26% total phenolic compounds including flavonoids
and tannoids. The extract was dissolved in distilled water prior to
administration.
Experimental design. Adult male albino Wistar rats
weighing 150–180 g were divided in to four groups of six animals
in each, procured from National Institute of Nutrition, Hyderabad,
India. Atherogenesis was induced by s.c., injection of ISO 85 mg/kg
body weight, dissolved in physiological saline, twice at an interval
of 24 h for two consecutive days. AMFE was pretreated to rats
orally at a dose of 150 mg/kg body weight/day for a period of 45
days, and then administered ISO at the dose of 85 mg/kg body
weight. All the groups were fed with standard pellet diet (M/s.
Hindustan Lever Ltd., Mumbai, India) and water ad libitum. The
dose of AMFE used in the present work was fixed based on the
acute oral toxicity study. The present study was approved by Sri
Krishnadevaraya University institutional animal ethical committee.
At the end of the experimental period, the rats in each group were
fasted overnight and then sacrificed by cervical dislocation. Blood
was collected with anticoagulant by cardiac puncture and plasma
was separated for various biochemical estimations.
In vitro assays. The effect of AMFE on various free radicals
using standardized methods as described previously.(22) The ability
to scavenge the stable free radical, DPPH (1,1-diphenyl-2-picryl
hydrazyl) was measured as a decrease in absorbance at 517 nm
and the percentage of inhibition was calculated. Nitric oxide (NO•)
generated from sodium nitroprusside was measured by the Greiss
reaction.(23) The absorbance of the chromophore formed during
diazotization of nitrite with sulfanilamide and subsequent
coupling with napthylethylene diamine was read at 546 nm and
percentage of inhibition was calculated. The hydroxyl radical (OH•)
scavenging activity of AMFE was measured by the deoxyribose
method.(24) The absorbance of the resulting solution was measured
spectrophotometrically at 532 nm and percentage of inhibition
was calculated. The ability to scavenge the super oxide radical
(O2•) of AMFE was measured.(25) Superoxide radical generated in
PMS-NADH system by oxidation of NADH was assayed by the
reduction of NBT at 560 nm. The total antioxidant capacity was
assessed based on the ability of a compound to scavenge the stable
ABTS radical (decolourisation assay).(26) ABTS+ generated by
oxidation of ABTS (1.8 mM) with potassium persulfate (2 mM).
The reaction mixture contained ABTS (0.002 M), AMFE (50–
1,000 μg) and buffer in a total volume of 3.5 ml. The absorbance
was measured at 734 nm in a UV-visible spectrophotometer. IC50
value in the concentration of sample required scavenging 50%
ABTS free radical.
Biochemical analysis of plasma and cardiac tissue. The 
heart was immediately washed with ice cold 0.9% saline and
homogenate was prepared in 0.1 N Tris HCl buffer (pH 7.4). The
homogenate was centrifuged and the clear supernatant was
collected for the assay. The Serum and cardiac tissue levels of
AST and ALT were assayed,(27) LDH enzyme activity was
estimated by the method described previously(28) and CK-MB
enzyme activity was determined as described.(29) Thiobarbituric
acid reactive substances (TBARS) were determined by measuring
the formation of malondialdehyde.(30) The plasma vitamin C level
was estimated and the values are expressed as mg/dl.(31)
Cardiac antioxidant status. Superoxide dismutase (SOD)
activity was determined.(32) A single unite of enzyme was expressed
as 50% inhibition of NBT (nitro blue tetrazolium) reduction/min/
mg protein while glutathione peroxidase (GPx) was assayed.(33)
GPx activity was expressed μmol GSH oxidized/min/mg protein.
Glutathione-S-transferase (GST) activity was measured as
described previously.(34) GST activity expressed as μmoL CDNB
utilized/min/mg protein. Total reduced glutathione (GSH) content
was measured by the method described.(35) Catalase (CAT) was
assayed as described.(36) The CAT activity was expressed as nmoL
H2O2 decreased/mg protein/min.
Histopathological examination. The hearts were fixed in
10% formalin solution and embedded in paraffin. The fixed tissues
were processed routinely, and were then embedded in paraffin,
sections measuring 4 μm thickness were made and deparaffinized
and rehydrated using standard techniques. The sections stained
with hematoxylin and eosin (H&E) and observed microscopically.
The severity and extent of cardiac damage were noted for each
specimen.
Statistical analysis. Statistical analysis was performed using
one way analysis of variance (ANOVA) followed by Duncan’s
Multiple Range Test (DMRT). Results were expressed as
mean ± SEM of six rats in each group. p values <0.05 was consid-
ered significant.
Results
Fig. 1 shows the percentage scavenging action of AMFE on free
radical generation. AMFE scavenges DPPH radicals in a dose-
dependent manner (50–1,000 μg). a) DPPH radical radical
scavenging, b) O2•, c) NO•, d) OH• and e) ABTS+ radical
scavenging activities were followed on dose-dependent (50–
1,000 μg). At lower doses there was poor effect has been traced.
However, at higher dose AMFE showed significant free radical
scavenging property.
Table 1 depicts the levels of plasma marker enzymes such as
AST, ALT, LDH and CK-MB in control and different experi-
mental groups. In ISO administered rats the levels of these marker
enzymes were increased significantly compared with control rats.
The rats pretreated with AMFE showed significant decrease in the
same when compared to ISO administered rats.
The cardiac marker enzymes viz. AST, ALT, LDH and CK-MB
of control and different experimental groups is presented in
Table 2. In ISO administered group their levels were significantly
decreased compared to control. Rats pretreated with AMFE
showed significant increase and maintained to near normal levels
compared to ISO alone administered rats.
As reported in Table 3, there was significant decrease in GSH,
GPx, and SOD levels in the heart tissue of ISO administered rats,
compared to normal rats. Pretreatment with AMFE resulted in
marked improvement in these indices at the end of the experiment
and were reverted back to normal level, compared to ISO-
administered rats. In addition, the significantly increased activity
of CAT observed in rats pretreated with AMFE, compared to ISO-
administered rats where as CAT activity is decreased significantly
in ISO administered rats compared to control.
The vitamin C levels in plasma of control and experimental
animals were showed in Fig. 2(a). The levels of vitamin C
decreased partially in ISO administered rats, compared to control
rats, AMFE pretreatment brought vitamin C levels to normal in
ISO treated rats. Fig. 2 shows the levels of TBARS in plasma (b)
and cardiac tissue (c) of control and experimental animals. The
TBARS levels were significantly higher in ISO administered
rats compared to controls where as in AMFE pretreated rats the
same was decreased significantly when compared to ISO alone
administered rats.
Histological changes of heart tissue sections of all groups of rats
were carried out by light microscopy study and showed in Fig. 3
(group I–IV). Cardiac sections of the ISO alone administered rat
showed edema, focal hemorrhage and leukocyte infiltration with
fragmentation of muscle fibers suggesting of necrosis (group II).
The AMFE pretreated rat heart showed a normal myofibrillar
structure with striations, branched appearance and continuity with
adjacent myofibrils when compared to ISO administered group
heart sections (group III). The AMFE treated rats showed a well-
preserved normal morphology of cardiac muscle with no evidence
of focal necrosis when compared to the ISO administered rat heart
(group IV). Hence, from the histological evidence it is clear that J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 201
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Fig. 1. Effect of various concentrations of AMFE on (a) scavenging of 1,1-diphenyl-2-picryl hydrazyl (DPPH) radicals, (b) super oxide radical
scavenging activity, (c) nitric oxide (NO) radicals, (d) hydroxyl radical scavenging activity, (e) ABTS+ radical scavenging activity. The values are
expressed as % scavenging activity. Values are mean ± SEM of three individual experiments.
Table 1. Effect of AMFE on plasma AST, ALT, LDH and CK-MB enzyme activities in ISO treated rats
Values are mean ± SEM of six rats in each group. a,b,cMeans in the same row not sharing a common
superscript are significantly different (p<0.05) among groups. All values are expressed as IU/L.
Parameter Control ISO AMFE AMFE + ISO
AST 27.6 ± 1.04a 78.6 ± 0.70b 28.3 ± 0.21a 32.7 ± 0.88a
ALT 28 ± 0.79a 43.2 ± 1.01b 28.5 ± 0.76a 28.2 ± 0.72a
LDH 91.8 ± 1.11a 164.1 ± 3.41c 88.8 ± 1.58a 105.5 ± 1.24b
CK-MB 230 ± 4.91a 331.9 ± 3.19c 232.5 ± 3.90a 243.9 ± 3.76bdoi: 10.3164/jcbn.11-69
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AMFE has protective nature against ISO-induced myocardial
injury.
Discussion
Therapeutic interventions could improve impaired antioxidant
defense mechanisms or diminish free radical production in
ischemic myocardium has been of great interest.(37) Generally
antioxidants, preferably from natural sources, have been consid-
ered as effective treatments.(38,39) Reactive nitrogen species (RNS)
are an important mediator of many physiological functions, and
its role in the pathogenesis of cardiovascular disease (CVD) is
gaining recognition. Higher concentration of NO has been
reported to be injurious to the tissue.(40) Our results in the present
study showed that AMFE scavenges hydroxyl radical, nitric oxide
radical and superoxide radical scavenging activity which are dose
dependent. In the present study, AMFE also showed total anti-
oxidant activity on dose dependent manner. The ability to retard
lipid oxidation is attributable to the phenolic compounds present
in AMFE which can quench ROS and RNS.(41)
The microscopic histopathological observations of heart sections
of ISO treated rats showed hemorrhage in myocardium and epi-
cardium as well as demarcated lesions particularly in the apical
portion of the heart. In animals ISO develop myocardial infarction
like lesions through β-adrenergic receptors, stimulating calcium
intracellular influx-increasing cAMP levels and exhausting high-
energy phosphates.(42) These lesions are morphologically similar
to myofibrillar degeneration, myocardial hypertrophy, myocyte
damage and cardiomyopathy including MI.(7) AMFE pretreated
rats showed normal myofibrillar structures with striations,
branched appearance and continuity with adjacent myofibrils.
AMFE effectively prevented the adverse effects caused by ISO
treatment and offered protection.
Further analysis of tissue damage marker enzymes in serum
namely AST, ALT, LDH and CK-MB showed increased activities
following ISO injection. Increase in AST/ALT ratio has clearly
Table 2. Effect of AMFE on cardiac tissue AST, ALT, LDH and CK-MB enzyme activities in ISO treated rats
Values are mean ± SEM of six rats in each group. a,b,cMeans in the same row not sharing a common
superscript are significantly different (p<0.05) among groups. All values are expressed as IU/L.
Parameter Control ISO AMFE AMFE + ISO
AST 48.3 ± 0.78a 33.6 ± 0.65b 48.9 ± 0.84a 49.4 ± 0.74a
ALT 33.7 ± 0.74a 23.1 ± 0.72b 33.4 ± 0.60a 34.9 ± 0.82a
LDH 159.4 ± 1.69a 93.1 ± 0.98b 33.4 ± 0.60a 157.4 ± 2.71a
CK-MB 19.40 ± 0.32a 13.7 ± 0.50b 19.6 ± 0.37a 20.6 ± 0.60a
Table 3. Effect of AMFE on cardiac tissue antioxidant enzyme levels in ISO treated rats
Values are mean ± SEM of six rats in each group. a,b,cMeans in the same row not sharing a common superscript are significantly different (p<0.05)
among groups.
Parameter Control ISO AMFE AMFE + ISO
GSH (μmoL/mg protein) 7.40 ± 0.80a 4.15 ± 0.34b 7.45 ± 0.42a 7.37 ± 0.77a
GPx (μmol of GSH consumed/min/mg protein) 3.42 ± 0.17a 1.81 ± 0.13b 3.52 ± 0.22a 3.54 ± 0.16a
GST (μmol of GSH-CDNB conjugate formed/min/mg protein) 18.49 ± 1.99a 9.85 ± 2.24b 18.56 ± 2.19a 18.61 ± 1.20a
SOD (U/mg protein/min) 7.41 ± 0.58a 4.30 ± 0.32b 7.48 ± 0.61a 7.30 ± 0.55a
CAT (H202 decomposed/mg protein/min) 47.23 ± 2.71a 25.96 ± 1.02c 46.13 ± 1.76a 49.33 ± 2.38b
Fig. 2. Effect of AMFE administration on (a) plasma vitamin C, (b) plasma TBARS and (c) cardiac tissue TBARS levels in ISO treated rats. Values are
mean ± SEM of six rats in each group. The means sharing a common letter are not significantly different among groups. J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 203
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showed damage and confirmed on set of MI. When myocardial
cells are damaged, the cell membrane becomes permeable, which
results in the leakage of these products. This might be the reason
for increased activities of cardiac marker enzymes in serum and
cardiac tissue of ISO-administered rats. Pretreatment with AMFE
lowered the elevated activities of these enzymes in serum and
maintained near to normal activities in cardiac tissue comparable
to the ISO alone administered rats. This is an indication of the
protective action of AMFE in reversing cardiac cell damage and
membrane permeability due to ISO.
Increased plasma levels of ascorbic acid in AMFE treated rats,
indicated its beneficial effect in the prevention of MI. Ascorbic
acid is a biologically active reductant, an excellent hydrophilic
antioxidant in plasma and disappear faster than other antioxidants
when plasma is exposed to ROS.(43) The decrease in plasma
ascorbic acid in ISO administered rats may be due to increased
utilization as an antioxidant defense against increased ROS or due
to a decrease in GSH level, since GSH is required for the recycling
of ascorbic acid.(44) The rats pretreated with AMFE restored the
plasma ascorbic acid level near to those of control group. The
restoration of ascorbic acid levels could be due to improvement in
endogenous antioxidant levels by free radical scavenging property
of AMFE.
Lipid peroxidation is an important pathogenic event that has
been linked to altered membrane structure and enzyme inactiva-
tion in myocardial infarction.(8) The levels of TBARS were signifi-
cantly elevated in the plasma and heart tissue of ISO-administered
rats. The elevated levels of TBARS observed in ISO administered
rats might be due to comparatively low levels of antioxidant
enzymes and increased oxidative stress.(45) The rats pretreated
with AMFE showed reduced levels of lipid peroxidation when
compared to ISO administered rats. Polyphenols present in AMFE
might be responsible for antilipoperoxidative effect. Antioxidants
are substances which can prevent or retard the oxidation of
biomolecules such as lipids, proteins and DNA.(46) Our results
showed lower levels of reduced glutathione content and a decrease
in the activities of CAT, SOD, GST and GPx in the heart tissue of
ISO administered rats as compared to control group. It could be
due to the increased generation of ROS such as superoxide and
hydrogen peroxide, which in turn leads to the inhibition of
activities of these enzymes. The rats pretreated with AMFE
showed an increase in GSH and significant elevation in the
activities of all the above antioxidant enzymes when compared to
ISO alone administered group. The data obtained in the present
study indicated the protective nature of the AMFE against oxida-
tive stress induced injury to cardiac tissue. Our lab reports also
confirmed that besides AMFE antioxidant activity it showed
hypolipidemic activity.(47) The increase in the levels of these
enzymes might be due to the supply of exogenous antioxidants in
the form of AMFE. The antioxidant properties of plant extracts
have been attributed to their phenolic compound contents. Several
epidemiological studies have been clearly indicated the beneficial
effects of phenolic compounds as natural antioxidants.(48) The
multi hydroxyl groups in the chemical structure of polyphenols
make them ideal for free radical-scavenging reactions and as
metal chelating agents.
In conclusion, the present study clearly demonstrated the
antioxidant activity and membrane stabilizing property of phenolic
compounds present in AMFE could ameliorate the occurrence of
heart related diseases which is supported by in vitro assays and
histopathological observations. The mechanism of action of the
phenolic compounds present in AMFE to attenuate cardiac tissue
damage needs further in-depth study.
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Abbreviations
ALT alanine transferase
AMFE Aegle marmelos fruit extract
ANOVA analysis of variance
AST aspartate transferase
CAT catalase
CK-MB creatinine kinase
CVD cardiovascular disease
DMRT Duncan’s multiple range test
DPPH 1,1-diphenyl-2-picryl hydrazyl
GPx glutathione peroxidase
GSH reduced glutathione
GST glutathione-S-transferase
IHD ischemic heart diseases
ISO isoproterenol
LDH lactate dehydrogenase
MI myocardial infarction
NBT nitro blue tetrazolium
NO nitric oxide
O2• super oxide radical
OH• hydroxyl radical
RNS reactive nitrogen species
ROS reactive oxygen species
SOD superoxide dismutase
TBARS thiobarbituric acid reactive substances
Fig. 3. Representative photomicrograph shows normal architecture of
heart of the control group. Endocardium and pericardium are seen
within normal limits with no infiltration of inflammatory cells (group I).
Photomicrograph of a rat heart subjected to ISO induced focal loss of
myofibers, myonecrosis, marked edema, and infiltration of chronic in-
flammatory cells. In subendocardium vacuolar changes and prominent
edema along with chronic inflammatory cells are clearly visible (group
II). Photomicrograph of the heart of an AMFE treated rats showed pre-
vention of myonecrosis as evidenced by significant reduction in focal
loss of myofibers and infiltration of inflammatory cells. Degree of ede-
ma also was markedly reduced with AMFE treatment (group IV). AMFE
alone administered rat cardiomyocytes showed control rat signs (group
III), original magnification, ×100.doi: 10.3164/jcbn.11-69
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